Mogens Guldberg

General Manager at Novo Nordisk Pharma, Austria

Head of Biopharm Business Unit. Manage Italian Biopharm P&L in accordance with agreed principles and targets. Manage and develop personnel in the business unit. Provide leadership and direction for our product portfolio in the Italian Biopharm unit and in relation to Key Opinion Leaders. Participate in establishing the European strategy and secure implementation locally. Chairman of European Biopharm Board.

Head of Biopharm Marketing, Europe South. Responsible of all marketing activities within the biopharmaceutical product portfolio in southern Europe (Spain, Greece, Portugal, and Italy). Including launches, business development, strategic and market planning, tactical marketing, project management, coaching and motivation of staff.

Head of HBU Operations. Driving force in setting up a new European Haematology Business Unit (HBU) in Zürich. Responsibilities included: European business planning including Profit & Loss responsibility, development of the strategic long term plan, sales & marketing effectiveness, responsibility for strategic evaluation and final implementation of all pan-European IT installations and support (eTMS/KWEB etc), all aspects of the internal finance activities.

Global Task Force / Marketing Effectiveness. Projects launched and implemented in the following countries (France, Sweden, Italy, Poland, China, Australia, India, Japan). Main objectives: introduce quantitative and qualitative effectiveness tools, assessment of growth opportunities, determination of largest growth opportunities, implement marketing investment plans to capture these growth potentials, and follow up to secure implementation.

World Class Track & Field athlete obtaining several Danish and Scandinavian records. Some of these still stand today.